Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Sandwich, Kent CT13 9NJ, United Kingdom
Epanutin Ready Mixed Parenteral 250 mg/5 ml Solution for Injection or Infusion.
| Pharmaceutical Form |
|---|
|
Solution for Injection or Infusion. Clear, colourless, sterile solution. |
Each 5 ml ampoule contains phenytoin sodium 250 mg (50 mg/ml).
Excipients with known effect: Each 5 ml also contains 440.4 mg ethanol 96% and 24.6 mg of sodium.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Phenytoin |
Phenytoin is effective in various animal models of generalised convulsive disorders, reasonably effective in models of partial seizures but relatively ineffective in models of myoclonic seizures. It appears to stabilise rather than raise the seizure threshold and prevents spread of seizure activity rather than abolish the primary focus of seizure discharge. |
| List of Excipients |
|---|
|
Each 5 ml contains: Propylene glycol |
5 ml, colourless neutral glass, Type 1, Ph Eur, with a white colour break band. Each pack contains 10 ampoules.
Pfizer Limited, Sandwich, Kent CT13 9NJ, United Kingdom
PL 00057/0527
Date of latest renewal: 1st March 2004
| Drug | Countries | |
|---|---|---|
| EPANUTIN | Austria, Cyprus, Spain, Ireland, Israel, Malta, Netherlands, Poland, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
